why choose us

First received: July 24, 2023

Clinical Trial: A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: SARS-CoV-2

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Randomized, Active-controlled, Observer-blind Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Booster Dose of Investigational COVID-19 mRNA Vaccines in Healthy Adults Who

Brief Summary: The purpose of Part A of this study is to assess the immune response and safety of a booster dose of investigational COVID-19 mRNA vaccines in healthy adults.The study will compare the investigational vaccines to control vaccine.The purpose of Part B of this study is to assess the immune response and safety of a booster dose of investigational COVID-19 mRNA vaccines in healthy adults.The study will compare the investigational vaccine under three different storage conditions.

Read more